Back to Awarded Treatment Trials


Awarded Trial: 02-STN-006

Grant ID

02-STN-006

Illness

Schizophrenia

Primary Drug/Intervention

Hydroxychloroquine

Primary Dosage

200mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Desta

Sample Size

61

Duration of Study Period for Each Subject

20 weeks

Outcome Measurements

PANSS

Results

In a trial of 61 patients this antimalarial drug failed to show beneficial effects.

Publication

Desta M, Tadesse A, Gebre N, Barci BM, Torrey EF, Knable MB. Controlled trial of hydroxychloroquine in schizophrenia. J Clin Psychopharmacol. 2002 Oct;22(5):507-10.

Link

http://www.ncbi.nlm.nih.gov/pubmed/12352275

PI Name

Menelik Desta

Degree

MD

Center

N/A

Institution

Amanuel Hospital

Address

PO Box 1971

City or Town

Addis Ababa

State or Province

N/A

Zip or Postal Code

N/A

Country

Ethiopia

Email Address

menelikdesta@hotmail.com